• Publications
  • Influence
One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation.
AIMS In the current study we assess the impact of two different access-site suture-mediated closure devices (SMCD), ProGlide and Prostar, on vascular and bleeding complications after transfemoralExpand
  • 22
  • 1
  • PDF
Stem-cell homing and tissue regeneration in ischaemic cardiomyopathy
In endstage cases, the last option for treatment is cardiac transplantation, which is limited by the small number of organs available. This situation raises the urgent need for alternativeExpand
  • 28
  • 1
Thrombectomy recovers an aortic wall fragment from middle cerebral artery immediately after TAVI
An 80-year-old woman underwent transcatheter aortic valve implantation (TAVI) using an Edward Sapien S3 device to treat symptomatic severe aortic stenosis, with a 0.8 cm2 aortic valve area.
  • 5
  • 1
Aortic regurgitation with second versus third-generation balloon-expandable prostheses in patients undergoing transcatheter aortic valve implantation.
AIMS Our aim was to assess the incidence of aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) with the second (SXT) versus third-generation (S3) balloon-expandable SAPIENExpand
  • 28
  • PDF
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement.
OBJECTIVES The purpose of the study was to investigate the impact of oral anticoagulation (OAC) type on clinical outcomes 1 year after transcatheter aortic valve replacement (TAVR). BACKGROUNDExpand
  • 15
Connexin 40 Promoter-Based Enrichment of Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells
Background: Pluripotent embryonic stem (ES) cells that can differentiate into functional cardiomyocytes as well as vascular cells in cell culture may open the door to cardiovascular cellExpand
  • 6
  • PDF
Long-term follow-up and predictors of target lesion failure after implantation of everolimus-eluting bioresorbable scaffolds in real-world practice.
BACKGROUND Bioresorbable scaffolds (BRS) have been shown to be inferior to drug-eluting stents in randomized trials. Nevertheless, patients treated during daily routine differ from those treatedExpand
  • 3
Bestehen Beziehungen der Kreatinverwertung zur Ovarialfunktion?
  • H. Theiss
  • Medicine
  • Archiv für Gynäkologie
  • 1 March 1934
ZusammenfassungDie Tatsache, daß gesunde geschlechtsreife Frauen sowohl im Intervall des Zyklus — also zur Zeit der ovariellen Hormonproduktion —wie zur Zeit der Menstruation — die Zeit derExpand
  • 1
Better Outcomes with Sapien 3 vsSapien XT balloon-expandable prosthesis inpatients undergoing transfemoral aortic valve replacement
Institut de Chirurgie Cardiaque et de Cardiologie Interventionnelle, Luxembourg, Luxembourg, SHG-Kliniken Völklingen, Völklingen, Germany, Ev. Klinikum Duisburg, Duisburg, Germany, HerzundExpand
Stromal-Derived Factor 1a (Sdf-1a), a Homing Factor for Mesenchymal Progenitor Cells, Is Elevated in Tumor Tissue and Plasma of Glioma Patients
Malignant gliomas are a fatal disease lacking sufficient possibilities for early diagnosis and chemical markers to detect remission or relapse. The recruitment of progenitor cells such as mesenchymalExpand